JP2023539699A5 - - Google Patents
Info
- Publication number
- JP2023539699A5 JP2023539699A5 JP2023537886A JP2023537886A JP2023539699A5 JP 2023539699 A5 JP2023539699 A5 JP 2023539699A5 JP 2023537886 A JP2023537886 A JP 2023537886A JP 2023537886 A JP2023537886 A JP 2023537886A JP 2023539699 A5 JP2023539699 A5 JP 2023539699A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073172P | 2020-09-01 | 2020-09-01 | |
| US63/073,172 | 2020-09-01 | ||
| US202163154461P | 2021-02-26 | 2021-02-26 | |
| US63/154,461 | 2021-02-26 | ||
| US202163160575P | 2021-03-12 | 2021-03-12 | |
| US63/160,575 | 2021-03-12 | ||
| PCT/US2021/048537 WO2022051304A1 (en) | 2020-09-01 | 2021-08-31 | Ionic liquid formulations for treating diabetes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539699A JP2023539699A (ja) | 2023-09-15 |
| JPWO2022051304A5 JPWO2022051304A5 (https=) | 2025-05-01 |
| JP2023539699A5 true JP2023539699A5 (https=) | 2025-05-01 |
Family
ID=80491938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537886A Pending JP2023539699A (ja) | 2020-09-01 | 2021-08-31 | 糖尿病を治療するためのイオン性液体製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240130994A1 (https=) |
| EP (1) | EP4208160A4 (https=) |
| JP (1) | JP2023539699A (https=) |
| KR (1) | KR20230098144A (https=) |
| AU (1) | AU2021336289A1 (https=) |
| CA (1) | CA3191276A1 (https=) |
| IL (1) | IL301024A (https=) |
| MX (1) | MX2023002510A (https=) |
| WO (1) | WO2022051304A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4429704A4 (en) | 2021-11-10 | 2025-11-05 | I2O Therapeutics Inc | IONIC LIQUID COMPOSITIONS |
| WO2025264979A1 (en) * | 2024-06-21 | 2025-12-26 | I2O Therapeutics, Inc. | Compositions comprising pharmaceutically acceptable salts and other derivatives of dual glp-1/amylin receptor agonists and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1886677A1 (en) * | 1996-07-26 | 2008-02-13 | Susan P. Perrine | Use of an inducing agent for the treatment of blood, viral and cellular disorders |
| GB0407908D0 (en) * | 2004-04-07 | 2004-05-12 | Univ York | Ionic liquids |
| IL312865B2 (en) * | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| AU2015249035A1 (en) * | 2014-11-14 | 2016-06-02 | Zoran Ivanov | Compositions and methods for treatment or prophylaxis of a liver condition |
| US20160177222A1 (en) * | 2014-12-19 | 2016-06-23 | The Procter & Gamble Company | Ionic liquid systems |
| CN111918644A (zh) * | 2017-11-17 | 2020-11-10 | 哈佛大学校长及研究员协会 | 用于内部递送的离子液体 |
| EP3768240A4 (en) * | 2018-03-19 | 2021-12-22 | Cage Bio Inc. | COMPOSITIONS OF IONIC LIQUID FOR THE TREATMENT OF ROSACEA |
| US20220257767A1 (en) * | 2019-04-03 | 2022-08-18 | President And Fellows Of Harvard College | Ionic liquids for drug delivery |
| JP2024518169A (ja) * | 2021-05-05 | 2024-04-25 | アイ２オー セラピューティクス，インク． | 炎症性疾患および自己免疫疾患を処置するためのイオン性液体製剤 |
| WO2023286120A1 (ja) * | 2021-07-12 | 2023-01-19 | 国立大学法人九州大学 | 経皮吸収剤 |
-
2021
- 2021-08-31 AU AU2021336289A patent/AU2021336289A1/en active Pending
- 2021-08-31 EP EP21865002.6A patent/EP4208160A4/en active Pending
- 2021-08-31 JP JP2023537886A patent/JP2023539699A/ja active Pending
- 2021-08-31 KR KR1020237010621A patent/KR20230098144A/ko active Pending
- 2021-08-31 CA CA3191276A patent/CA3191276A1/en active Pending
- 2021-08-31 MX MX2023002510A patent/MX2023002510A/es unknown
- 2021-08-31 IL IL301024A patent/IL301024A/en unknown
- 2021-08-31 WO PCT/US2021/048537 patent/WO2022051304A1/en not_active Ceased
-
2023
- 2023-02-28 US US18/176,094 patent/US20240130994A1/en active Pending